In clinical studies the numbers are unusual for a sleep aid: DSIP increased total sleep time by about 59% in one trial, normalized sleep in people with chronic insomnia in another, and, most strikingly, several of those patients kept normal sleep for 3 to 7 months after their last injection
Sleep Apnea and Kidney Disease Separate ongoing TRIUMPH Phase 3 trials are evaluating retatrutide in patients with moderate-to-severe obstructive sleep apnea and in adults with chronic kidney disease and obesity
Some studies suggest fewer heart-related events in people with obesity who take GLP-1 drugs, possibly due to weight loss and other effects
Improvement in blood pressure was also reversed
Based on current clinical evidence: Mounjaro (tirzepatide) Wegovy (semaglutide 2.4 mg) Ozempic (semaglutide) Semaxa (oral semaglutide) However, individual responses vary considerably
Deep Cleansing & Detox: Gently removes dirt, oil, and impurities without over-drying